Ultrahypofractionated radiotherapy yields non-inferior 10-year survival outcomes compared to conventional treatment in ...
World Cancer Day collaboration supports clearer, more inclusive access to cancer clinical trials By hosting the ...
By KATRINA BRANDON DONATIONS have opened up opportunities at Latrobe Regional Hospital (LRH) thanks to Latrobe's Biggest Ever ...
ROANOKE, Va. (WDBJ) - September is Prostate Cancer Awareness Month, for a cancer that’s more common than you might realize. WDBJ7’s Logan Sherrill spoke with survivors who want other men to know ...
When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery ...
A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...
Hosted on MSN
Biden prostate cancer latest: Joe and Jill thank public for support and say ‘we are strongest in the broken places’
Former president Joe Biden has issued his first public message since it was revealed on Sunday that he has been diagnosed with an aggressive form of prostate cancer. “Cancer touches us all,” the ...
Patients with nonmetastatic prostate cancer are more likely to die from other causes than from cancer when treated per guidelines. The 15-year cancer mortality risk is 5.5% for low-risk and 22% for ...
We urgently need research to understand the factors driving ethnic inequalities in prostate cancer outcomes, say Habib Naqvi ...
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to treat overactive bladder symptoms, reduces hot flashes compared to the ...
The Urology Unit of Federal Teaching Hospital (FTH), Lokoja has held its maiden Prostate Cancer Support Group Meeting to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results